Molecular and pathophysiological pathways—such as TGF-β1 signaling—play a key role in atrial remodeling and fibrosis, offering potential targets for AI-guided therapeutic strategies in atrial fibrillation [43]. Here, TGFB1 is linked to atrial fibrillation.